Document:

EXHIBIT 10.07

 

 

DIRECTOR INDEMNIFICATION
AGREEMENT

 

NEXEON MEDSYSTEMS
INC

 

 

THIS
DIRECTOR INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of ___________, 2016, by and among Nexeon MedSystems
Inc, a Nevada corporation (the “Company”), and _____________________, an individual who is a Director of the Company
(the “Indemnitee”).

 

Article
I

 

RECITALS:

 

A.        The
Indemnitee has been elected to serve as a Director of the Company and the Company wishes the Indemnitee to serve in such capacity.

 

B.        The
General Corporation Law of the State of Nevada, under which law the Company is organized, empowers corporations to indemnify a
person serving as a director, officer, employee or agent of the corporation and a person who serves at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, or other enterprise, and
the Bylaws of the Company (the “Bylaws”) specify that the indemnification set forth shall not be deemed exclusive
of any other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or
disinterested directors or otherwise.

 

C.        The
Board of Directors of the Company has concluded that, to retain and attract talented and experienced individuals to serve as officers
and directors of the Company, and to encourage such individuals to take the business risks necessary for the success of the Company,
it is necessary for the Company contractually to indemnify officers and directors and to assume for itself liability for expenses
and damages in connection with claims against such officers and directors in connection with their service to the Company.

 

D.        The
Board of Directors has determined that contractual indemnification as set forth herein is not only reasonable and prudent but
necessary to promote the best interests of the Company and its stockholders.

 

E.        The
Company desires and has requested the Indemnitee to serve or continue to serve as a Director of the Company free from undue concern
for claims for damages arising out of or related to such services to the Company, which may impair the free exercise of Indemnitee’s
best business judgment on behalf of the Company, its subsidiaries and other enterprises affiliated with the Company.

 

F.        The
Indemnitee is willing to serve, or to continue to serve, the Company, only on the condition that the Company furnishes the indemnity
provided for herein.

 

    	1

    	 

    

 

NOW, THEREFORE, in
consideration of the Indemnitee’s service as a Director of the Company, the parties hereto agree as follows:

 

1.         Agreement
to Serve. The Indemnitee shall serve as a director of the Company, at the will of the Company at the election of its stockholders,
in the capacity the Indemnitee currently serves, so long as the Indemnitee is duly appointed or elected and qualified in accordance
with the applicable provisions of the Bylaws and Certificate of Incorporation of the Company, as such may be amended or restated
from time to time, or until such time as the Indemnitee tenders a resignation in writing; provided, however, that nothing contained
in this Agreement is intended to create any right to continued employment, if any, by the Indemnitee in any capacity.

 

2.         Indemnity.

 

(a)      The Company will indemnify the Indemnitee, the Indemnitee’s executors, administrators or assigns, for any Expenses (as defined
below), which the Indemnitee is or becomes legally obligated to pay in connection with any Proceeding (as defined below); provided,
that in each such case the Indemnitee has acted in good faith and in a manner which the Indemnitee reasonably believed to be in
or not opposed to the best interests of the Company, and, in the case of a criminal proceeding, in addition, had no reasonable
cause to believe that the conduct at issue was unlawful. The termination of any action, suit or proceeding by judgment, order,
settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption
that the Indemnitee did not act in good faith and in a manner which the Indemnitee reasonably believed to be in or not opposed
to the best interests of the Company, or, with respect to any criminal action or proceeding, had reasonable cause to believe that
the conduct at issue was unlawful.

 

(b)      As used in this Agreement the term “Proceeding” shall mean any threatened, pending or completed action, suit or proceeding,
whether brought by or in the right of the Company or by a third party or otherwise and whether of a civil, criminal, administrative
or investigative nature, in which the Indemnitee may be or may have been involved as a party or otherwise, by reason of the fact
that the Indemnitee is or was a director or officer of the Company, by reason of any action taken by or any inaction on the part
of the Indemnitee while acting as such director or officer, or by reason of the fact that the Indemnitee was serving at the request
of the Company as a director, trustee, officer, employee or agent of another corporation, partnership, joint venture, trust or
other enterprise.

 

(c)      For purposes of this Agreement the term “subsidiary” means any corporation of which more than 50% of the outstanding
voting securities are owned directly or indirectly by the Company, by the Company and one or more other subsidiaries or by one
or more other subsidiaries.

 

(d)      As used in this Agreement, the term “other enterprise” shall include (without limitation) employee benefit plans and
administrative committees thereof, and the term “fines” shall include (without limitation) any excise tax assessed
with respect to any employee benefit plan.

 

(e)      References to “serving at the request of the Company” shall include any service as a director, officer, employee or
agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect
to an employee benefit plan, its participants or beneficiaries, and if the Indemnitee acted in good faith and in a manner the
Indemnitee reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan, the Indemnitee
shall be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to above.

 

    	2

    	 

    

 

3.         Expenses.
As used in this Agreement, the term “Expenses” shall include, without limitation, damages, judgments, fines, penalties,
settlements and costs, reasonable attorneys’ fees and disbursements and costs of attachment or similar bonds, investigations,
and any reasonable expenses of establishing a right to indemnification under this Agreement.

 

4.         Subrogation.
In the event that the Company pays any Expenses under this Agreement, the Company shall be subrogated to the extent of such
payment to all of the rights of recovery of the Indemnitee, who shall execute all papers required and shall do everything that
may be necessary to secure such rights, including the execution of such documents necessary to enable the Company effectively
to bring suit to enforce such rights.

 

5.         Exclusions.
Notwithstanding the foregoing, the Company shall not be liable under this Agreement to pay any Expenses in connection with any
Proceeding:

 

(a)      to the extent that payment of such Expenses is actually made to the Indemnitee under a valid, enforceable and collectible insurance
policy;

 

(b)      to the extent that the Indemnitee is indemnified and actually paid other than pursuant to this Agreement;

 

(c)      in connection with a judicial action by or in the right of the Company, in respect of any claim, issue or matter as to which the
Indemnitee shall have been adjudged to be liable to the Company unless and only to the extent that the Court of Chancery of the
State of Delaware or the court in which such Proceeding was brought shall determine upon application that, despite the adjudication
of liability but in view of all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for
such Expenses as such court shall deem proper;

 

(d)      if it is proved by final judgment in a court of law or other final adjudication that the Indemnitee had in fact gained any personal
profit or advantage to which the Indemnitee was not legally entitled;

 

(e)      for a disgorgement of profits made from the purchase and sale by the Indemnitee of securities pursuant to Section 16(b) of the
Securities Exchange Act of 1934 and amendments thereto or similar provisions of any state statutory law or common law;

 

(f)      if it is proved by final judgment in a court of law or other final adjudication that the Indemnitee breached the duty of loyalty
owed to the Company or its stockholders, acted in bad faith, failed to act where such failure to act was in bad faith, or engaged
in intentional misconduct or knowing violation of the law; or

 

(g)      for any Expenses which the Company is prohibited by applicable law from paying as indemnity.

 

6.         Indemnification
of Expenses of Successful Party. Notwithstanding any other provision of this Agreement, to the extent that the Indemnitee
has been successful on the merits or otherwise in defense of any Proceeding or in defense of any claim, issue or matter therein,
including dismissal without prejudice, the Indemnitee shall be indemnified against any and all Expenses actually and reasonably
incurred in connection therewith.

 

    	4

    	 

    

 

7.         Partial
Indemnification. If the Indemnitee is entitled under any provision of this Agreement to indemnification by the Company
for some or a portion of Expenses, but not, however, for the total amount thereof, the Company shall nevertheless indemnify the
Indemnitee for the portion of such Expenses to which the Indemnitee is entitled

 

8.         Advance
of Expenses. Expenses incurred by the Indemnitee in connection with any Proceeding shall be paid by the Company in advance
of the final disposition thereof upon request of the Indemnitee that the Company pay such Expenses. The Indemnitee hereby undertakes
to repay to the Company the amount of any Expenses theretofore paid by the Company to the extent that it is ultimately determined
that such Expenses were not reasonable or that the Indemnitee is not entitled to indemnification therefore. The advances to be
made hereunder shall be paid by the Company to or on behalf of the Indemnitee within 30 days following delivery of a written request
therefore by the Indemnitee to the Company, which request shall be accompanied by such supporting documentation as the Company
may reasonably request.

 

9.         Notice
of Claim; Control. The
Indemnitee, as a condition precedent to any indemnification under this Agreement shall give to the Company notice in writing as
soon as reasonably practicable of any Proceeding for which indemnity will or could be sought under this Agreement. Notice to the
Company shall be given in accordance with Section 17 hereof. In addition, the Indemnitee shall give the Company such information
and cooperation as it may reasonably require and as shall be within the Indemnitee’s power and shall give the Company the
right, at its option, to control any responses thereto and the defense and/or settlement thereof using counsel selected by the
Company. The Indemnitee shall not enter into any settlement of any Proceeding without the prior written consent of the Company.

 

10.         Modification
and Waiver.
No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties
hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision
hereof (whether or not similar), nor shall such waiver constitute a continuing waiver.

 

11.         Changes
in Law/Amendments. The entitlement of the Indemnitee to
payment hereunder shall not be affected or diminished by any amendment, termination or repeal of the General Corporation Law
of the State of Delaware or the Bylaws of the Company with respect to any Proceeding arising out of or relating to any
actions, transactions or facts occurring prior to the final adoption of any such amendment, termination or
repeal.

 

12.         Enforcement.
In the event that the Company shall fail or refuse to make payment of any Expenses due the Indemnitee under Section 2 hereof
within the time periods provided in Section 8, which failure is not cured within thirty (30) days after written notice of such
failure is received by the Company from the Indemnitee, the parties shall engage in arbitration in Charleston, West Virginia in
accordance with the commercial arbitration rules then in effect of JAMs/Endispute, before a panel of three arbitrators, one of
whom shall be selected by the Company and one by Indemnitee, and the third of whom shall be selected by the other two arbitrators.
It is expressly understood and agreed by the parties that a party may compel arbitration pursuant to this Section 12 through an
action for specific performance and any award entered by the arbitrators shall be final, binding and nonappealable and judgment
may be entered thereon by either party in accordance with applicable law in any court of competent jurisdiction. The arbitrators
shall have no authority to modify any provision of this Agreement or to award a remedy for dispute involving this Agreement other
than a benefit specifically provided under or by virtue of the Agreement. Unless otherwise determined by the arbitrator, each
party shall be responsible for its own expenses relating to the conduct of the arbitration (including reasonable attorneys’
fees and expenses) and shall equally share the fees of the American Arbitration Association.

 

    	5

    	 

    

 

13.         Counterparts.
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one instrument.

 

14.         Indemnification
Hereunder Not Exclusive. Nothing herein shall be deemed to diminish or otherwise restrict the Indemnitee’s right
to indemnification under any provision of the Certificate of Incorporation or the Bylaws of the Company and amendments thereto
or under law.

 

15.         Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware.

 

16.         Consent
to Jurisdiction. The
Company and the Indemnitee each hereby irrevocably consent to the jurisdiction of the courts of the State of Delaware for all
purposes in connection with any action or proceeding that arises out of or relates to this Agreement.

 

17.         Notice.
All notices, requests, demands and other communications under
this Agreement shall be in writing and shall be deemed duly given: (a) if delivered by hand and signed for by the party addressee;
or (b) if mailed by certified or registered mail, with postage prepaid, on the third business day after the mailing date; or (c)
if delivered by nationally recognized overnight express courier to an address within the United States on the next business day
after the deposit with such courier; or (d) if delivered by internationally recognized international express courier service to
address outside the United States on the second business day after deposit with such courier. Addresses for notice to either party
are as shown on the signature page of this Agreement or as subsequently modified by written notice.

 

18.         Saving
Clause. Wherever
there is conflict between any provision of this Agreement and any applicable present or future statute, law or regulation contrary
to which the Company and the Indemnitee have no legal right to contract, the latter shall prevail, but in such event the affected
provisions of this Agreement shall be curtailed and restricted only to the extent necessary to bring them within applicable legal
requirements.

 

19.         Coverage.
The provisions of this Agreement shall apply with respect
to the Indemnitee’s service as a Director of the Company prior to the date of this Agreement (if any) and with respect to
all periods of such service after the date of this Agreement, even though the Indemnitee may have ceased to be a Director of the
Company and shall inure to the benefit of the heirs, executors and administrators of the Indemnitee.

 

    	6

    	 

    

 

20.         Survival
of Agreement. For purposes of this Agreement, any reference to the “Company” shall include, in addition to
the resulting or surviving corporation, any constituent corporation (including any constituent of a constituent) absorbed in a
consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors,
officers, employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation,
or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Agreement
with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation
if its separate existence had continued.

 

IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be duly executed and signed as of the day and year first above written.

 

	 	NEXEON MEDSYSTEMS INC
	 	 
	 	 
	 	 By:	
	 	 	Ron Conquest, CEO

 

INDEMNITEE:

 

By:
______________________________________

 

    	7EXHIBIT 99.01

 

 

NEXEON
PATENT PORTFOLIO

NANOTUBE-REINFORCED
BALLOONS FOR DELIVERING PATENTS

	#	Patent/App #	Title
	1	US 8187221	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	2	US 13/455,919	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	3	US 13/455,973	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	4	AU2009269104	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	5	CA2730273A1	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	6	CN102176932 A	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	7	EP2313121 A2	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	8	JP2011527601 A	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	9	JP5481479 B2	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME
	10	WO2010005575	THERAPEUTIC AGENTS WITHIN OR BEYOND THE WALL OF BLOOD VESSELS,  AND METHODS  OF MAKING  AND USING SAME

 

IRIS FILTER-SHEATH CATHETER SYSTEM FOR
EMBOLISM PROTECTION PATENTS

 

	11	US 8257384	INTERVENTIONAL CATHETER FOR RETROGRADE USE HAVING EMBOLIC PROTECTION CAPABILITY AND METHODS OF USE
	12	US 7837702	INTERVENTIONAL CATHETER FOR RETROGRADE USE HAVING EMBOLIC PROTECTION CAPABILITY AND METHODS OF USE
	13	US 20130253570	APPARATUS AND METHODS FOR FILTERING EMBOLI DURING PERCUTANEOUS AORTIC VALVE PROCEDURES AND REPAIR PROCEDURES WITH FILTRATION SYSTEM COUPLED IN-SITU TO DISTAL END OF SHEATH
	14	US 20130253571	APPARATUS AND METHODS FOR FILTERING EMBOLI DURING PERCUTANEOUS AORTIC VALVE PROCEDURES AND REPAIR PROCEDURES WITH FILTRATION SYSTEM COUPLED IN-SITU TO DISTAL END OF SHEATH

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}]]